'Scaffold-Hopping' by topological pharmacophore search: A contribution to virtual screening

Angewandte Chemie - International Edition

Volumn 38, Issue 19, 1999, Pages 2894-2896

  Schneider, Gisbert ^a   Neidhart, Werner ^a   Giller, Thomas ^a   Schmid, Gerard ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Computer chemistry; Drug research; Structure activity relationships; Virtual screening

Indexed keywords

ARTICLE; COMPUTER PROGRAM; DRUG CONFORMATION; DRUG RESEARCH; DRUG TARGETING; PHARMACOPHORE; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; VIRTUAL REALITY;

EID: 0033523672     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F     Document Type: Article

References (23)

1. a) Molecular Similarity in Drug Design (Ed.: P. M. Dean), Chapman & Hall, Glasgow, 1995;
2. b) G. Schneider, W. Schrödl, G. Wallukat, J. Müller, E. Nissen, W. Rönspeck, P. Wrede, R. Kunze, Proc. Natl. Acad. Sci. USA 1998, 95, 12179-12184;
3. c) P. Willett, J. M. Barnard, G. M. Downs, J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
4. a) G. W. Milne, M. C. Nicklaus, S. Wang, SAR QSAR Environ. Res. 1998, 9, 23-38;
5. b) H. Briem, I. D. Kuntz, J. Med. Chem. 1996, 39, 3401-3408.
6. a) J. Sadowski, J. Gasteiger, Chem. Rev. 1993, 93, 2567-2581;
7. b) R. S. Bohacek, C. McMartin, Curr. Opin. Chem. Biol. 1997, 1, 157-161.
8. a) R. D. Brown, Y. C. Martin, SAR QSAR Environ. Res. 1998, 8, 23-39;
9. b) H. Matter, J. Med. Chem. 1997, 40, 1219-1229.
10. G. Schneider, P. Wrede, Prog. Biophys. Mol. Biol. 1998, 70, 175-222, and references therein.
11. a) G. Moreau, P. Broto, Nouv. J. Chim. 1980, 4, 757-764;
12. b) M. Wagener, J. Sadowski, J. Gasteiger, J. Am. Chem. Soc. 1995, 117, 7769-7775;
13. c) S. Anzali, W. W. K. R. Mederski, M. Osswald, D. Dorsch, Bioorg. Med. Chem. Lett. 1997, 8, 11-16;
14. d) D. D. Jones, J. Theor. Biol. 1975, 50, 167-183.
15. M. Vieth, J. D. Hirst, C. L. Brooks III, J. Comput. Aided Mol. Des. 1998, 12, 563-72.
16. a) C. Kettner, E. Shaw, Methods Enzymol. 1981, 80, 824-826;
17. b) P. D. Grootenhuis, M. Karplus, J. Comput. Aided Mol. Des. 1996, 10, 1-10.
18. a) S. I. Ertel, E. A. Ertel, Trends Pharmacol. Sci. 1997, 18, 37-42;
19. b) D. Sarsero, T. Fujiwara, P. Molenaar, J. A. Angus, Br. J. Pharmacol. 1998, 125, 109-119.
20. 2+ channel was expressed in HEK293 cells, and the inhibition by the compounds was monitored using a fluorescence assay. T. Giller, unpublished results.
21. J. Qar, J. P. Galizzi, M. Fosset, M. Lazdunski, Eur. J. Pharmacol. 1987, 141, 261-268.
22. D. R. Liu, P. G. Schultz, Angew. Chem. 1999, 111, 36-56; Angew. Chem. Int. Ed. 1999, 38, 36-54.
23. D. R. Liu, P. G. Schultz, Angew. Chem. 1999, 111, 36-56; Angew. Chem. Int. Ed. 1999, 38, 36-54.